Fasenra: Side Effects, Cost, Dosage, and More

If severe asthma has been running your life like an unpaid managercalling the shots, scheduling surprise flare-ups,
and insisting you cancel plansbiologic medicines can feel like a plot twist. Fasenra (benralizumab) is one of those
“targeted” treatments: it doesn’t replace your inhalers, but for the right person it can reduce exacerbations, cut down
steroid use, and help breathing feel less like a full-time job.

This guide breaks down the practical stuff people actually Google at 1 a.m.: side effects (common and serious), real-world
cost, dosage schedules, how the injections work, and what to expect once you start.

Quick Snapshot (Because Life Is Busy)

• Generic name: benralizumab
• Brand name: Fasenra
• What it treats: severe asthma with an eosinophilic phenotype (adults and kids age 6+); EGPA in adults
• How it’s given: subcutaneous injection (prefilled syringe or autoinjector pen)
• Typical asthma schedule: every 4 weeks for 3 doses, then every 8 weeks
• Common side effects: headache, sore throat/pharyngitis; sometimes fever (pyrexia)
• Big “call your clinician now” risk: allergic reactions (including anaphylaxis)

What Is Fasenra?

Fasenra is a prescription biologic medication (a monoclonal antibody) used as an add-on maintenance treatment for
people with severe asthma who have an eosinophilic phenotype. In plain English: it’s for a specific type of severe asthma
where eosinophils (a kind of white blood cell) are playing a starring role in airway inflammation.

Fasenra is also approved to treat adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare form of vasculitis
that often appears in people with asthma and high eosinophil levels.

How Fasenra Works (A Friendly Nerd Moment)

Fasenra targets the interleukin-5 receptor alpha (IL-5Rα) on eosinophils. By binding to that receptor, it helps reduce
eosinophils through a process called antibody-dependent cell-mediated cytotoxicity (ADCC). Fewer eosinophils can mean less
inflammation driving severe asthma symptoms and exacerbations.

You don’t need to memorize that for trivia night. The takeaway is: it’s a targeted therapy aimed at a specific immune pathway,
not a general “turn everything down” medication like oral steroids.

Who Is Fasenra For?

1) Severe eosinophilic asthma (age 6 and older)

Fasenra is approved for adults and pediatric patients age 6+ with severe asthma and an eosinophilic phenotype. It is
not for sudden rescue relief (it won’t replace a rescue inhaler) and it’s not meant for treating acute bronchospasm
or status asthmaticus.

Clinicians typically consider biologics when asthma remains poorly controlled despite high-dose inhaled corticosteroids (ICS)
plus other controller medicines, and when biomarkers (like blood eosinophils) and clinical history suggest an eosinophilic pattern.

2) EGPA (adults)

Fasenra is approved for the treatment of adults with EGPA (eosinophilic granulomatosis with polyangiitis). EGPA is an immune-mediated
vasculitis that can affect multiple organs and is often associated with asthma and elevated eosinophils. Because it’s rare and complex,
diagnosis and management usually involve specialists (often rheumatology, allergy/immunology, and pulmonology working together).

Dosage and Administration

Fasenra is given as a subcutaneous injection (under the skin). The dosing schedule depends on what it’s treating and (for kids)
sometimes depends on weight.

Asthma dosing (adults and adolescents 12+)

• 30 mg injected every 4 weeks for the first 3 doses
• Then 30 mg every 8 weeks thereafter

Pediatric asthma dosing (ages 6–11)

For kids ages 6–11, dosing is weight-based:

• Less than 35 kg: 10 mg every 4 weeks for the first 3 doses, then every 8 weeks
• 35 kg or more: 30 mg every 4 weeks for the first 3 doses, then every 8 weeks

Important practical note: in children ages 6–11, Fasenra should be administered by a caregiver or healthcare providernot self-injected.

EGPA dosing (adults)

• 30 mg injected every 4 weeks

Where and how the injection is given

Injections are typically given in the thigh or abdomen. The upper arm can also be used if a healthcare provider or caregiver
administers it. Your clinician may start the first dose(s) in-office, then transition to at-home administration with the Fasenra Pen
if appropriate and after training.

The prescribing information includes practical steps like letting the carton sit at room temperature for about 30 minutes before injecting,
checking the liquid for discoloration/particles, and rotating injection sites. With the autoinjector, you generally press firmly until you hear
a click, and hold it in place for the full injection (commonly about 15 seconds) so you receive the entire dose.

If you miss a dose

If you miss a dose, contact your healthcare provider for instructions. Don’t “double up” on your own or freestyle your schedule
biologics do best when you’re consistent.

Storage basics (the “don’t ruin a $6K pen” section)

Fasenra is typically stored in the refrigerator (around 36°F to 46°F / 2°C to 8°C). The manufacturer also allows limited room-temperature
storage (commonly up to 14 days at 68°F to 77°F / 20°C to 25°C). Always follow the specific storage guidance on your product packaging
and your pharmacist’s instructions.

Fasenra Side Effects

Most people tolerate Fasenra well, but side effects can happen. Below are the side effects most often reported in clinical studies and in
patient information, plus the “red flag” reactions that require urgent attention.

Most common side effects

• Headache
• Sore throat / pharyngitis

Other reported reactions include fever (pyrexia) and injection-site reactions (like pain, redness, itching, or a small bump).
Injection-site reactions were uncommon overall and occurred at similar rates to placebo in major asthma trials.

Serious side effects to know

The main serious risk called out for Fasenra is hypersensitivity (allergic) reactions. These can include rash, hives, swelling,
breathing difficulty, dizziness/lightheadedness, or symptoms consistent with anaphylaxis. Allergic reactions can occur within hours
or be delayed by days. If you suspect a serious allergic reaction, seek emergency care.

Side-effect management tips (not glamorous, but helpful)

• Headache: Hydrate, rest, and ask your clinician what’s safe for you (especially if you have other conditions or take other meds).
• Sore throat: Warm fluids, lozenges, and monitoring; contact your clinician if symptoms persist or are severe.
• Injection-site reactions: Rotate sites, let alcohol dry fully, and consider a cool pack afterward if approved by your clinician.
• Track patterns: Note timing (same day vs. next day), severity, and whether symptoms worsen over time.

Warnings and Precautions (The Stuff You Shouldn’t Skip)

Not for acute asthma symptoms

Fasenra is a maintenance therapy, not a rescue medication. If you have sudden wheezing or shortness of breath, follow your asthma action plan
and use your rescue treatment as directed.

Don’t stop steroids abruptly

If you use oral corticosteroids or inhaled steroids, do not stop them suddenly when starting Fasenra. Steroid reductionswhen appropriateshould
be gradual and supervised by your clinician to avoid withdrawal symptoms or a flare of disease that steroids were suppressing.

Parasitic (helminth) infections

Eosinophils may play a role in the immune response to certain parasitic infections. Patients with known helminth infections are typically treated
before starting therapy. If a parasitic infection occurs and doesn’t respond to treatment, clinicians may pause Fasenra until the infection resolves.

Drug interactions

No formal drug-drug interaction studies were conducted for Fasenra, and an effect on the pharmacokinetics of commonly co-administered medications
is not expected based on available data. Still, always disclose your full medication list (including supplements) to your healthcare team.

How Long Does Fasenra Stay in Your System?

Like many monoclonal antibodies, Fasenra doesn’t vanish overnight. After subcutaneous administration, the reported elimination half-life is about
15.5 days. That’s one reason dosing can eventually space out to every 8 weeks for asthma maintenance. Translation: you’re not “starting over”
from zero between injections, and it may take time to see the full benefit.

How Much Does Fasenra Cost?

Let’s talk moneybecause pretending cost doesn’t matter is a cute fantasy. The manufacturer publishes a list price that can serve as a ballpark,
but it’s rarely what insured patients actually pay out of pocket.

List price (manufacturer-reported)

• $6,022.46 for the 30 mg/mL dose (commonly used for adults and many adolescents/kids ≥35 kg)
• $2,007.49 for the 10 mg/mL dose (used for children 6–11 who weigh under 35 kg)

Your real cost depends on insurance (commercial vs. Medicare/Medicaid), whether the drug is billed under the medical benefit (clinic-administered)
or pharmacy benefit (home administration), your deductible, coinsurance, and whether prior authorization is required.

Ways people lower out-of-pocket costs

• Manufacturer support: A savings program may cover eligible commercially insured patients’ out-of-pocket costs (often up to a yearly cap),
  and some patients can pay as little as $0 depending on eligibility.
• Patient assistance: AstraZeneca’s patient assistance pathway (such as AZ&Me) may help certain uninsured patients or those who still
  can’t afford the medication even with Medicare.
• Plan strategy: If your plan resets deductibles yearly, some people schedule high-cost specialty care strategically (with clinician approval),
  especially if multiple treatments are happening in the same year.
• Ask about administration site: Sometimes the cost differs if doses are given in an infusion/injection clinic vs. shipped as a specialty pharmacy product.

Practical tip: when you call insurance, ask two separate questions: “Is Fasenra covered?” and “Under which benefitmedical or pharmacy?” That one detail
often explains 80% of the surprise bills.

What Results Can You Expect?

For the right patients, Fasenra can reduce asthma exacerbations and improve symptom control as part of a broader asthma plan. Some people notice fewer
“bad weeks,” fewer urgent visits, and less reliance on oral steroids. Others see modest change. Biologics are powerful, but they’re not magic wands
your baseline disease, triggers, adherence to inhaled therapy, and comorbid conditions (like chronic rhinosinusitis, GERD, or obesity) still matter.

For EGPA, Fasenra’s approval was supported by clinical trial evidence, including remission outcomes and the ability for some patients to reduce or stop oral
corticosteroids under medical supervision. Because EGPA varies widely, response and tapering plans are individualized.

Alternatives to Fasenra (Biologic “Cousins”)

Fasenra is one of several biologics used for severe asthma. Your clinician may consider alternatives based on your asthma phenotype (eosinophilic vs. allergic),
biomarkers, symptoms, comorbidities, and prior treatment response. Other biologics include treatments that target IgE, IL-5, IL-4/IL-13 pathways, or upstream
inflammatory signals. Switching is sometimes considered when response is incomplete after an adequate trial.

FAQ

Is Fasenra a steroid?

No. It’s a biologic monoclonal antibody. In many patients it reduces the need for oral steroids over time, but it’s not itself a corticosteroid.

Can I stop my inhalers once I start Fasenra?

Don’t stop controller meds without your clinician’s guidance. Fasenra is add-on therapy, and inhaled corticosteroids remain a foundation for most severe asthma
treatment plans.

How soon does Fasenra start working?

Some people notice improvement within weeks, but meaningful changes often take several doses. Clinicians typically reassess after a few months, looking at
exacerbations, rescue inhaler use, symptoms, and sometimes biomarkers.

Can I use Fasenra during an asthma attack?

NoFasenra is not for immediate relief of acute symptoms. Use your rescue plan and seek care if symptoms are severe.

The “Real Life” Part: Experiences People Commonly Report (About )

Clinical trials tell you what happened on average. Real life tells you what it feels like on a random Tuesday when you’re juggling work, kids, and an
immune system that thinks pollen is a personal insult. Here are common themes patients and caregivers often describe when starting Fasenrashared as
practical observations, not medical advice.

1) The schedule feels oddly…freeing

People who’ve been stuck in a loop of flare-ups and steroid bursts often say the biggest “quality of life” change isn’t just breathing betterit’s the
mental relief of fewer emergencies. The asthma dosing schedule (every 4 weeks at first, then every 8 weeks) can feel manageable compared with daily
medication routines that still don’t fully control symptoms. Many describe planning around injection weeks the way others plan around oil changes:
predictable, mildly annoying, but ultimately helpful.

2) The first few doses are a learning curve

In the beginning, people tend to overthink everything: “Was that click loud enough?” “Did I hold it long enough?” “Is this tiny red spot normal or am I
about to become a medical mystery?” With training, the process usually becomes routine. A small injection-site reaction (redness, itch, mild swelling)
can happen, especially early on. Many find that rotating sites and letting the medication warm to room temperature helps make the injection more comfortable.

3) Headache and sore throat are the usual ‘ugh’ moments

When side effects do show up, patients often mention headache or a sore throat. Most describe these as mild-to-moderate and short-lived. A common pattern:
symptoms that appear within a day of dosing and fade within a couple of days. People who track symptoms in a notes app (or on paper, if you’re a retro
legend) often find it easier to explain what’s happening to their clinicianand to reassure themselves that they’re not imagining patterns.

4) Insurance paperwork can be the hardest side effect

No one puts “prior authorization” on a gratitude list, but it’s a frequent part of the biologic experience. Patients often describe a multi-step journey:
documentation of severe asthma, confirmation of eosinophilic phenotype, proof of controller therapy use, then approval. Some people get quick coverage;
others deal with appeals. When it’s frustrating, many patients report that specialty pharmacy nurses, manufacturer support programs, and proactive clinic staff
make a real differenceespecially if they help coordinate benefits and dosing logistics.

5) The biggest wins are often boring (in the best way)

People describe success as “quiet” improvements: fewer night awakenings, less panic packing a rescue inhaler, fewer missed school days, fewer urgent care visits,
andwhen appropriategradually lowering oral steroid use under supervision. It’s not always dramatic. Sometimes it’s just the return of normal life activities:
walking the dog without wheezing, playing with kids, or sleeping through the night. In chronic illness, boring can be beautiful.

Conclusion

Fasenra is a targeted biologic option for severe eosinophilic asthma (age 6+) and EGPA (adults). Its dosing schedule is relatively convenient, its most common
side effects are typically headache and sore throat, and the most important safety concern is the possibility of serious allergic reactions. Cost can be substantial,
but insurance coverage and manufacturer support programs may reduce out-of-pocket expenses for eligible patients.

If you’re considering Fasenra, the best next step is a focused conversation with your specialist: confirm phenotype, review exacerbation history, compare biologic
options, and map out an insurance plan. Your lungs deserve a treatment strategynot a series of emergency improvisations.